MedPath

Effect of N-acetylcysteine on preventation of postcardiac surgery atrial fibrillatio

Phase 2
Conditions
Atrial fibrillation.
Atrial fibrillation and flutter
Registration Number
IRCT201008134561N1
Lead Sponsor
Cardiac Research Center of Tabriz Universityof Medical sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
240
Inclusion Criteria

primary elective coronary artery and/or valve surgery, older than 18 years of age in normal sinus rhythm. Exclusion criteria: prior coronary
revascularization or heart valve surgery, emergency surgery, New York Heart Association class III or IV congestive heart failure, history of AF, hyperthyroidism, inflammatory diseases except coronary artery disease, infection, a left atrium size 70 mm, electrolyte imbalance, and ejection fraction 0.25

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Postoperative atrial fibrillation. Timepoint: before and up to 48h after surgery. Method of measurement: ECG holtermonitoring.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath